View in EDS HTML Full Text PDF Full Text

Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.

Saved in:
Bibliographic Details
Title: Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir.
Authors: Tadmor, Tamar1 (AUTHOR), Melamed, Guy2 (AUTHOR), Patalon, Tal2 (AUTHOR), Alapi, Hilel2 (AUTHOR), Rokach, Lior3 (AUTHOR)
Source: Leukemia & Lymphoma. May2023, Vol. 64 Issue 5, p1054-1056. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first